Please provide your email address to receive an email when new articles are posted on . Higher doses of zegocractin led to “significant reduction” in organ failure and necrotizing pancreatitis for ...
CalciMedica said it is “moving quickly” to take Auxora into phase 3 after the calcium release-activated calcium channel inhibitor was shown to reduce the time before solid food could be consumed by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results